![]() ITH Pharma ITH Pharma is a new pharmaceutical company committed to the research and development of aseptic preparations and to providing an unrivalled customer service. | ![]() Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company. | ![]() Divis Laboratories Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. | ||
Founding Date | Founding Date 2008 | Founding Date 1983 | Founding Date 1990 | Founding Date 1954 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Greater London, GB HQ | Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more | Locations Hyderabad, IN HQ Choutuppal, IN Thondangi, IN Visakhapatnam, IN Basel, CH Basel, CH Florham Park, US | Locations SI HQ |
Employees | Employees 1843% increase | Employees 43,000 | Employees 7,9267% increase | Employees 132,447 |
Financial | ||||
Revenue (est.) | Revenue (est.) £48.3m (FY, 2018) | Revenue (est.) ₹582.2b (FY, 2026) | Revenue (est.) ₹105.6b (FY, 2026) | Revenue (est.) €2b (FY, 2025) |
Cost of goods | Cost of goods £33.5m (FY, 2018) | Cost of goods ₹115.4b (FY, 2026) | Cost of goods ₹40.9b (FY, 2026) | Cost of goods €764m (FY, 2025) |
Gross profit | Gross profit £14.8m (FY, 2018) | Gross profit ₹488.9b (FY, 2026) | Gross profit ₹69.7b (FY, 2026) | Gross profit €1.3b (FY, 2025) |
Net income | Net income £3.1m (FY, 2018) | Net income ₹115.6b (FY, 2026) | Net income ₹25.7b (FY, 2026) | Net income €403.7m (FY, 2025) |

Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.
View company
Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates.
View company